1st Private Payor Positive Coverage Policy For A Novel & Proven Treatment For Lumbar Spinal Stenosis
- Lumbar Spinal Stenosis Affects 1.6 million U.S. Patients Annually
- Broad coverage policy issued by Blue Cross Blue Shield of Michigan for 6.1 million lives
- Coverage policy for coflex® Interlaminar Stabilization®
- coflex® is a non-fusion, motion-preserving implant for treatment of Lumbar Spinal Stenosis
- 4.5 million Blue Cross Blue Shield patients in Michigan will now have access to coflex®
- This is in addition to the already 4.1 million Michigan lives covered by Medicare, Medicaid & ACA
- Total coverage for coflex® now at 8.6 million lives approximately 82% of Michigan state population
NEW YORK, Sept. 26, 2017 /PRNewswire/ -- Paradigm Spine, LLC, a leader in providing solutions for the treatment of lumbar spinal stenosis, announces issuance of a Blue Cross Blue Shield of Michigan Medical Policy, entitled "Interspinous/Interlaminar Stabilization/Distraction Devices (Spacers)" dated September 1, 2017. The coverage policy may be found here https://www.bcbsm.com/mprApp/MedicalPolicyDocument?fileId=2112720.
Lumbar spinal stenosis ("LSS"), affecting 1.6 million patients annually, is a debilitating and degenerative disease in older patients (>50 yrs) often associated with significant leg and back pain, leg numbness and weakness, causing a significant reduction in an active lifestyle. Traditional surgical treatment options for LSS includes a decompression that removes bone and soft tissue and may also require a fusion to stabilize the spine. The coflex® device is a non-fusion, motion preserving stabilization implant, that is FDA PMA approved for the treatment of Lumbar Spinal Stenosis, and can be used in conjunction with a decompression or used in lieu of a spinal fusion.
To learn more about coflex® Interlaminar Stabilization®, please visit www.coflexsolution.com.
Matthew Songer MD, MBA, Assistant Professor College of Human Medicine, Michigan State University – "Over the last four years, I've treated 80 patients with coflex®. In comparison to fusion, coflex® is less-invasive, requires a short hospital stay, allows for a much quicker recovery with return-to-work time in as little as two weeks. In comparison to decompression-alone, coflex® adds durability to already good outcomes, while maintaining the fast recovery. I'm delighted insurance coverage will now be available to more of my patients."
Marc Viscogliosi, Chairman & CEO – "With over 85 peer-review published articles, including landmark 5 year follow-up studies, medical society guidelines, and now with commercial insurance coverage, it is wonderful to be able to expand patient access to the coflex® technology."
About Paradigm Spine, LLC
Paradigm Spine, LLC was founded in 2004 and remains focused on the design and development of solutions for the disease management of spinal stenosis. The Company's signature product is the coflex® Interlaminar Stabilization® device, which has more than 20 years of clinical history and patients treated in more than 40 countries worldwide.
SOURCE Paradigm Spine, LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article